239 related articles for article (PubMed ID: 6178498)
1. Colon-specific antigen-p (CSAp). I. Initial clinical evaluation as a marker for colorectal cancer.
Pant KD; Shochat D; Nelson MO; Goldenberg DM
Cancer; 1982 Sep; 50(5):919-26. PubMed ID: 6178498
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of carcinoembryonic antigen and epithelial membrane antigen expression in normal colon, adenomas and adenocarcinomas of the colon and rectum.
Davidson BR; Sams VR; Styles J; Dean C; Boulos PB
Gut; 1989 Sep; 30(9):1260-5. PubMed ID: 2806995
[TBL] [Abstract][Full Text] [Related]
3. Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen.
Gupta MK; Arciaga R; Bocci L; Tubbs R; Bukowski R; Deodhar SD
Cancer; 1985 Jul; 56(2):277-83. PubMed ID: 2408729
[TBL] [Abstract][Full Text] [Related]
4. Carcinoembryonic antigen: clinical and historical aspects.
Martin EW; Kibbey WE; DiVecchia L; Anderson G; Catalano P; Minton JP
Cancer; 1976 Jan; 37(1):62-81. PubMed ID: 1247968
[TBL] [Abstract][Full Text] [Related]
5. Colon-specific antigen-p (CSAp). II. Further characterization in colorectal and pancreatic cancer.
Shochat D; Pant KD; Goldenberg DM
Cancer; 1982 Sep; 50(5):927-31. PubMed ID: 6807529
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of the tumor markers CEA and CA 19-9 in colorectal diagnosis].
Heptner G; Domschke S; Krapf F; Schneider MU; Iro H; Domschke W
Dtsch Med Wochenschr; 1984 Aug; 109(35):1309-12. PubMed ID: 6590287
[TBL] [Abstract][Full Text] [Related]
7. Significance of measurement of a carbohydrate antigenic determinant 19-9 (CA 19-9) for monitoring colorectal cancer patients.
Tomoda H; Furusawa M
Jpn J Surg; 1986 Jan; 16(1):73-5. PubMed ID: 2421035
[TBL] [Abstract][Full Text] [Related]
8. Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases.
Kuusela P; Jalanko H; Roberts P; Sipponen P; Mecklin JP; Pitkänen R; Mäkelä O
Br J Cancer; 1984 Feb; 49(2):135-9. PubMed ID: 6582896
[TBL] [Abstract][Full Text] [Related]
9. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract].
Tappero G; Piantino P; Cerchier A; Pecchio F
Minerva Med; 1985 Apr; 76(16):765-70. PubMed ID: 2582313
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of adenocarcinomas of the colorectum with low levels of preoperative plasma carcinoembryonic antigen (CEA).
Jubert AV; Talbott TM; Maycroft TM
Cancer; 1978 Aug; 42(2):635-9. PubMed ID: 679156
[TBL] [Abstract][Full Text] [Related]
11. Serial levels of CA 19-9 and CEA in colonic cancer.
Novis BH; Gluck E; Thomas P; Steele GD; Zurawski VR; Stewart R; Lavin PT; Zamcheck N
J Clin Oncol; 1986 Jun; 4(6):987-93. PubMed ID: 2423655
[TBL] [Abstract][Full Text] [Related]
12. Carcinoembryonic antigen (CEA) monitoring of radiation therapy for colorectal cancer.
Sugarbaker PH; Bloomer WD; Corbett ED; Chaffey JT
AJR Am J Roentgenol; 1976 Oct; 127(4):641-4. PubMed ID: 970537
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of M43: a novel cancer-associated mucin epitope.
Goodgame R; Kiefe C; Rose E; Sutton F; Brown J; Alpert E
Cancer Res; 1993 Jun; 53(12):2803-9. PubMed ID: 7684947
[TBL] [Abstract][Full Text] [Related]
14. Patterns of serial CEA assays and their clinical use in management of colorectal cancer.
Sugarbaker PH; Skarin AT; Zamcheck N
J Surg Oncol; 1976; 8(6):523-37. PubMed ID: 994514
[TBL] [Abstract][Full Text] [Related]
15. Serum total gangliosides and TA90-IC levels: novel immunologic markers in colorectal cancer.
Perez CA; Ravindranath MH; Gupta RK; Tollenaar RA; van de Velde CJ; Wood TF; Soh D; Morton DL; Bilchik AJ
Cancer J; 2002; 8(1):55-61. PubMed ID: 11898807
[TBL] [Abstract][Full Text] [Related]
16. The value of CA 19-9 in gastric and colorectal carcinoma.
Safi F; Bittner R; Roscher R; Kübel R; Beger HG
Cancer Invest; 1987; 5(5):401-7. PubMed ID: 3480768
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactive carcinoembryonic antigen [CEA] levels in feces from colorectal cancer patients.
Kitsukawa Y
Jpn J Surg; 1979 Jun; 9(2):102-9. PubMed ID: 449127
[TBL] [Abstract][Full Text] [Related]
18. Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study.
Minton JP; Hoehn JL; Gerber DM; Horsley JS; Connolly DP; Salwan F; Fletcher WS; Cruz AB; Gatchell FG; Oviedo M
Cancer; 1985 Mar; 55(6):1284-90. PubMed ID: 3971297
[TBL] [Abstract][Full Text] [Related]
19. A prospective evaluation of serum carcinoembryonic antigen (CEA) levels in the management of colorectal carcinoma.
Boey J; Cheung HC; Lai CK; Wong J
World J Surg; 1984 Jun; 8(3):279-86. PubMed ID: 6464483
[No Abstract] [Full Text] [Related]
20. Tissue concentrations of CEA and CA 19-9 in the carcinogenesis of colorectal carcinoma exemplified by the adenoma-carcinoma sequence.
Fischbach W; Mössner J
Res Exp Med (Berl); 1988; 188(2):101-14. PubMed ID: 3163815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
